Emerging clinical concerns in the ageing haemophilia patient

@article{Konkle2009EmergingCC,
  title={Emerging clinical concerns in the ageing haemophilia patient},
  author={Barbara A. Konkle and Craig Kessler and Louis M Aledort and Janice Andersen and Patrick F. Fogarty and Peter A Kouides and Doris V Quon and Margaret V Ragni and Anaadriana Zakarija and Bruce M. Ewenstein},
  journal={Haemophilia},
  year={2009},
  volume={15}
}
Summary.  The availability of safe replacement clotting factor concentrates together with effective antiviral drugs to treat human immunodeficiency and hepatitis C viruses and the provision of care at designated haemophilia treatment centres have resulted in a new phenomenon in haemophilia management – the ageing patient. Today, increasing numbers of persons with haemophilia (PWH) are middle‐aged and older, and they face the same age‐related health issues as the general population. The impact… Expand
The aging patient with hemophilia
  • B. Konkle
  • Medicine
  • American journal of hematology
  • 2012
TLDR
This review will focus on issues related to management of hemophilia and complications of cardiovascular, musculoskeletal, hepatic, and renal disease. Expand
Emerging issues on comprehensive hemophilia care: preventing, identifying, and monitoring age-related comorbidities.
TLDR
A summary of the current knowledge on the aging PWH along with the clinical approaches that may be integrated into the routine comprehensive care of these patients for preventing, diagnosing, and monitoring age-related comorbidities is presented. Expand
Renal diseases in haemophilic patients: pathogenesis and clinical management
TLDR
The pathogenesis of renal damage in patients with haemophilia, especially in those with blood‐transmitted viral infections, and the major issues about the management of renal diseases, including problems related to dialytic treatment and kidney transplantation are discussed, providing practical algorithms to guide the clinical decision‐making process. Expand
Renal Replacement Therapy in a Haemophilic Patient: a Case Report
TLDR
A case of a patient affected by a severe form of haemophilia A, who presented advanced renal disease requiring the initiation of renal replacement therapy, which offers the possibility to examine the major issues regarding the management of dialysis treatment in ha Hemophilic patients. Expand
Challenges in treating elderly patients with haemophilia: a focus on cardiology.
TLDR
Current knowledge about cardiovascular risk in elderly haemophilia patients, recommendations for clinical decision making, and the authors' own experiences of managing individuals with coronary heart disease and atrial fibrillation are outlined. Expand
The evolution of comprehensive haemophilia care in the United States: perspectives from the frontline
  • L. Aledort
  • Medicine
  • Haemophilia : the official journal of the World Federation of Hemophilia
  • 2016
TLDR
The evolution of the comprehensive haemophilia care, while chastened by the viral epidemics of the 1980s, has been marked by ongoing advances, including prophylaxis, immune tolerance induction, new drugs and gene therapy research. Expand
Co‐morbidities and quality of life in elderly persons with haemophilia
TLDR
This review focuses on co‐morbidities in the ageing haemophilia patients, their impact on quality of life and their complex management. Expand
Management of Hemophilia in Older Patients
TLDR
This narrative review focuses on the clinical problems arising in older people with hemophilia, with particular attention to the optimal therapeutic strategies. Expand
How I treat age-related morbidities in elderly persons with hemophilia.
TLDR
More detailed advice is provided on the schedules of replacement therapy needed to tackle cardiovascular diseases, such as acute coronary syndromes and nonvalvular atrial fibrillation, because these conditions will become more and more frequent challenges for the comprehensive treatment centers. Expand
Clinical challenges within the aging hemophilia population.
TLDR
Prospective studies are needed to address challenges related not only to hemophilia but also to general comorbidity associated with aging so that evidence-based guidance can be given to clinicians who treat older patients with Hemophilia. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 173 REFERENCES
Haemophilia and ageing
Summary.  Men with haemophilia have not only the challenges of living with HIV and/or HCV infection and premature arthritis as complications of their disorder, but they also confront the other ailsExpand
Cardiovascular disease in patients with hemophilia
TLDR
Mortality due to ischemic heart disease in hemophilia patients is lower as compared to the general male population, but it remains unclear whether the deficiency of coagulation factor VIII or IX exerts a protective effect on the development of atherosclerosis. Expand
Comparing outcomes of different treatment regimens for severe haemophilia
TLDR
Data indicate that both prophylaxis regimens resulted in significantly improved long-term outcomes, as assessed by pain, clinical and radiological assessment scores, suggesting that the improvement in long‐term clinical outcomes and reduced risk of arthropathy may lead to reduced factor consumption in adult patients who received early proPHylactic therapy. Expand
Renal disease among males with haemophilia
TLDR
It was found that HIV infection and haemophilia‐related factors including inhibitors and kidney bleeds were associated with renal disease in a cohort of males with haemaphilia. Expand
When to start and when to stop primary prophylaxis in patients with severe haemophilia
  • J. Astermark
  • Medicine
  • Haemophilia : the official journal of the World Federation of Hemophilia
  • 2003
TLDR
Most available data indicate that prophylaxis should be started during the first years of life, and it may be possible to adjust the dose and dose interval depending on the bleeding pattern, which may improve cost‐effectiveness and make the use of this treatment modality more feasible. Expand
Management of haemostasis during haemodialysis in a patient with haemophilia B
TLDR
A 58-year-old male patient with severe haemophilia B had renal failure because of diabetes and needed dialysis, who received HD, and there was no clot formation in the extracorporeal circuit during dialysis and haemostasis was good enough after that. Expand
The natural history of chronic hepatitis C in haemophiliacs
TLDR
Multivariate analysis showed that HIV status, length of time since HCV infection and age atHCV infection were independently associated with both the development of cirrhosis and liver failure. Expand
[Treatment of chronic hepatitis C in haemophilia patients].
Adults with inherited disorders of coagulation have one of the highest prevalence rates of hepatitis C among known risk groups. Few data are available on the use of combination therapy withExpand
Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis C
TLDR
Although the data are limited, the procedure does not appear to pose excessive risk to the patient with inherited disorders of coagulation, provided that adequate haemostasis can be achieved prior to the liver biopsy. Expand
Haemophilia protects against ischaemic heart disease: a study of risk factors
TLDR
It is reported that mortality due to ischaemic heart disease was lower in haemophilia patients than in the general male population and the hypothesis that this could be attributed to a protective effect of the clotting defect in haenophilia is supported. Expand
...
1
2
3
4
5
...